Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
Clinical trial NCT04211389 · COMPLETED
Trial details
- NCT number
- NCT04211389
- Sponsor
- Arcutis Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-17
- Primary completion
- 2020-11-23
- Enrollment
- 442
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.